Globe Life Inc. (NYSE:GL - Free Report) - DOWLING & PARTN cut their FY2026 EPS estimates for Globe Life in a research report issued on Tuesday, October 27th. DOWLING & PARTN analyst J. Hurwitz now anticipates that the company will earn $15.55 per share for the year, down from their previous estimate of $15.80. The consensus estimate for Globe Life's current full-year earnings is $15.51 per share.
Globe Life (NYSE:GL - Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.90 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analysts' expectations of $1.56 billion. Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The business's quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business posted $4.81 EPS.
Other equities research analysts have also issued research reports about the stock. Jefferies Financial Group raised their price target on shares of Globe Life from $147.00 to $166.00 and gave the stock a "hold" rating in a research note on Friday, July 10th. UBS Group set a $165.00 price objective on Globe Life in a research note on Friday, October 23rd. Piper Sandler downgraded Globe Life from an "overweight" rating to a "neutral" rating and dropped their price objective for the company from $200.00 to $165.00 in a research note on Friday, October 23rd. Keefe, Bruyette & Woods reduced their price objective on Globe Life from $192.00 to $190.00 and set an "outperform" rating for the company in a report on Friday, July 24th. Finally, JPMorgan Chase & Co. raised their target price on Globe Life from $193.00 to $195.00 and gave the stock an "overweight" rating in a research report on Thursday, October 15th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $181.50.
View Our Latest Stock Report on Globe Life
Globe Life Stock Up 0.9%
GL opened at $158.42 on Thursday. Globe Life has a twelve month low of $127.85 and a twelve month high of $191.55. The company's 50-day moving average price is $168.76 and its two-hundred day moving average price is $159.45. The stock has a market cap of $12.17 billion, a price-to-earnings ratio of 10.60 and a beta of 0.44. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. purchased a new stake in shares of Globe Life during the second quarter worth $987,901,000. State Street Corp grew its position in shares of Globe Life by 2.1% in the second quarter. State Street Corp now owns 3,735,409 shares of the company's stock valued at $667,443,000 after purchasing an additional 76,745 shares in the last quarter. Dimensional Fund Advisors LP grew its position in shares of Globe Life by 10.2% in the first quarter. Dimensional Fund Advisors LP now owns 2,353,192 shares of the company's stock valued at $327,479,000 after purchasing an additional 217,331 shares in the last quarter. Pzena Investment Management LLC bought a new stake in shares of Globe Life during the 2nd quarter valued at $242,256,000. Finally, Swedbank AB raised its stake in shares of Globe Life by 15.3% during the 1st quarter. Swedbank AB now owns 1,109,200 shares of the company's stock valued at $154,367,000 after purchasing an additional 147,200 shares during the period. 81.61% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Globe Life
In related news, EVP Robert Hensley sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, September 22nd. The shares were sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the sale, the executive vice president directly owned 12,384 shares in the company, valued at approximately $2,106,146.88. This represents a 44.67% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Majors sold 14,377 shares of the company's stock in a transaction that occurred on Friday, October 23rd. The shares were sold at an average price of $154.48, for a total transaction of $2,220,958.96. Following the sale, the executive vice president owned 39,141 shares in the company, valued at $6,046,501.68. The trade was a 26.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 74,377 shares of company stock worth $13,043,159 over the last quarter. Corporate insiders own 2.11% of the company's stock.
Globe Life announced that its Board of Directors has initiated a share repurchase program on Monday, August 10th that permits the company to buy back $2.50 billion in shares. This repurchase authorization permits the company to reacquire up to 17.7% of its shares through open market purchases. Share repurchase programs are often an indication that the company's management believes its shares are undervalued.
Globe Life Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Monday, October 5th will be given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Monday, October 5th. Globe Life's dividend payout ratio (DPR) is currently 8.83%.
Globe Life Company Profile
(
Get Free Report)
Globe Life Inc NYSE: GL is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.
The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.